Update on Neuromodulation for Migraine and Other Primary Headache Disorders: Recent Advances and New Indications
Current Pain and Headache Reports · 2025-12 · 29 (1)
DOI: 10.1007/s11916-024-01314-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Pain and Headache Reports, online erschienen am 15.02.2025. Verfasst von Alexandra N Cocores und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology─Headache Division, University of Miami, Miller School of Medicine, 1120 NW 14Th Street, 13th floor, Miami, FL, 33136, USA. Hauptthemen laut MEDLINE: Migraine Disorders, Headache Disorders, Primary, Electric Stimulation Therapy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose of Review Neuromodulation techniques currently available for headache management are reviewed in this article, with a focus on recent advances in non-invasive devices for migraine and trigeminal autonomic cephalalgias. Recent Findings The currently available FDA-cleared non-invasive devices for migraine include transcutaneous supraorbital and supratrochlear nerve stimulation, single-pulse transcranial magnetic stimulation (sTMS), external concurrent occipital and trigeminal neurostimulation (eCOT-NS), remote electrical neuromodulation (REN), and non-invasive vagal nerve stimulation (nVNS) with indications for migraine and trigeminal autonomic cephalalgias. Emerging non-invasive techniques being explored for use in migraine include transcranial direct current stimulation (tDCS), kinetic oscillation stimulation (KOS), and auricular transcutaneous vagal nerve stimulation (at-VNS). In addition to primary headache, non-invasive neuromodulation is being investigated for comorbid conditions such as depression. Summary Non-invasive neuromodulation devices remain a safe, well-tolerated, and effective therapy for patients with primarily migraine and trigeminal autonomic cephalalgias. Ongoing research is needed to determine efficacy in other headache disorders and comorbid conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology─Headache Division, University of Miami, Miller School of Medicine, 1120 NW 14Th Street, 13th floor, Miami, FL, 33136, USA.
- Department of Neurology─Headache Division, University of Miami, Miller School of Medicine, 1120 NW 14Th Street, 13th floor, Miami, FL, 33136, USA. tmonteith@med.miami.edu.
Zitieren
APA
Cocores, A. N., Smirnoff, L., Greco, G., Herrera, R., & Monteith, T. S. (2025). Update on Neuromodulation for Migraine and Other Primary Headache Disorders: Recent Advances and New Indications. Current Pain and Headache Reports, 29(1). https://doi.org/10.1007/s11916-024-01314-7
Vancouver
Cocores AN, Smirnoff L, Greco G, Herrera R, Monteith TS. Update on Neuromodulation for Migraine and Other Primary Headache Disorders: Recent Advances and New Indications. Current Pain and Headache Reports. 2025;29(1). doi:10.1007/s11916-024-01314-7
BibTeX
@article{Cocores2025,
author = {Cocores, Alexandra N and Smirnoff, Liza and Greco, Guy and Herrera, Ricardo and Monteith, Teshamae S},
title = {Update on Neuromodulation for Migraine and Other Primary Headache Disorders: Recent Advances and New Indications},
journal = {Current Pain and Headache Reports},
year = {2025},
volume = {29},
number = {1},
doi = {10.1007/s11916-024-01314-7}
}
EUVIMED